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Abstract
Background: It was previously reported that an association analysis based on haplotype clusters increased power
over single-locus tests, and that another association test based on diplotype trend regression analysis
outperformed other, more common association approaches. We suggest a novel algorithm to combine haplotype
cluster- and diplotype-based analyses.
Methods: Diplotyper combines a novel algorithm designed to cluster haplotypes of interest from a given set of
haplotypes with two existing tools: Haploview, for analyses of linkage disequilibrium blocks and haplotypes, and
PLINK, to generate all possible diplotypes from given genotypes of samples and calculate linear or logistic
regression. In addition, procedures for generating all possible diplotypes from the haplotype clusters and
transforming these diplotypes into PLINK formats were implemented.
Results: Diplotyper is a fully automated tool for performing association analysis based on diplotypes in a
population. Diplotyper was tested through association analysis of hepatic lipase (LIPC) gene polymorphisms or
diplotypes and levels of high-density lipoprotein (HDL) cholesterol.
Conclusions: Diplotyper is useful for identifying more precise and distinct signals over single-locus tests.
Background
Causal mutations for health conditions with genetic bases
can be identified through finding associations with haplo-
types, a form of correlation known as linkage disequili-
brium (LD) [1]. Investigating significant haplotype
structure has become a routine research activity. The
Haploview tool provides computation of LD and popula-
tion haplotype patterns from genotype data [2]. The
PLINK tool set [3] accomplishes diverse functions includ-
ing a module carrying out Expectation-Maximization
(EM) algorithm [4]. PLINK focuses on fast calculations
with large datasets. WHAP was developed to perform
haplotype-based association analysis in population and
family samples using single nucleotide polymorphism
(SNP) data [5]. An additional software tool was elabo-
rated for carrying out haplotype association analysis in
unrelated individuals [6]. To provide a detailed genome
structure, a recloning system [7] was developed to obtain
the sequences of 20 haplotypes from a chimpanzee and a
gorilla, across human leukocyte antigen (HLA) genes.
Meanwhile, rare haplotypes have been investigated to
identify their roles in influencing disease susceptibility.
Experimental data showed that two rare haplotypes of
parathyroid hormone-related peptide receptor type 1 and
vitamin D receptor genes, with frequencies of 1.1% and
2.9%, respectively, were significantly associated with osteo-
porosis phenotypes (P = 4.2 × 10-6 and P = 1.6 × 10-4,
respectively) [8]. Recently, haplotypes in the regulatory
regions of the HLA-G gene were examined to recognize
possible associations with the implantation outcome in
couples undergoing assisted reproduction treatments
(ART). The results revealed a complete absence of some
haplotypes in couples undergoing ART [9].
Notably, Durrant et al. proposed a novel approach to
investigate associations between diseases and haplotype
clusters in a logistic regression framework through cla-
distic analysis of SNP haplotypes. Substantial increases in
power over single-locus tests were demonstrated by the
simulation study. Their empirical data showed that a
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haplotype cluster that consisted of two haplotypes had
the strongest effect on Cystic Fibrosis (OR = 96.8) [10].
Luo et al. used a novel analysis, diplotype trend regres-
sion (DTR) analysis, to investigate associations between
certain diplotypes of alcohol dehydrogenase and aldehyde
dehydrogenase genes, and alcohol dependence. They
demonstrated that DTR outperformed other conven-
tional association methods [11]. Both articles indicated
that our new algorithm might provide a synergistic effect
through combining analyses based on both haplotype
clusters and diplotypes.
Here, we propose a novel method to investigate asso-
ciations between diplotypes and diseases. We define a
haplotype cluster as a set of haplotypes. We also define a
diplotype as a haplotype cluster pair, the definition of
which is extended from a haplotype pair. The first step of
our method uses the Haploview tool to generate all possi-
ble haplotypes. Second, all possible haplotype pairs
(diplotypes) from SNP genotypes of all samples are gen-
erated by PLINK. Third, all possible haplotype clusters
are generated by our clustering algorithm from the hap-
lotypes produced in the first step. Fourth, the patterns of
all possible diplotypes are generated from those haplo-
type clusters. Fifth, to calculate regression by PLINK, the
diplotypes of the samples are transformed into AA, AB,
or BB formats according to the diplotype patterns pro-
duced in the fourth step. Finally, PLINK was used with a
regression model to obtain the association results. All of
these procedures are performed automatically by the
software we developed, named Diplotyper, which was
implemented in Python 2.7.
We applied this method to an association study
between high-density lipoprotein cholesterol (HDL-C)
and the hepatic lipase (HL) gene. HL is involved in lipo-
protein metabolism through its bridging function, which
facilitates the interaction between lipoproteins and lipo-
protein receptors, and its activity plays an important role
in plasma lipoprotein metabolism and the atherosclerotic
process [12]. HL plays an important role in both reverse
cholesterol transport and non-cholesterol-dependent
mechanisms involved with HDL [13,14]. Changes in HL
activity can be associated with alterations in lipoprotein
composition, which may contribute to the development
of atherosclerosis [12,14]. Low HDL-C levels are risk fac-
tors for coronary heart and cardiovascular diseases
[15,16]. Extensive research has provided evidence that
increasing HDL-C levels can reduce the risk of cardiovas-
cular disease [17-20]. The risk of developing coronary
heart disease can be determined by the levels of HDL-C
[21]. In particular, a recent report, based on the Korea
National Health and Nutrition Examination Surveys I, II,
III and IV, shows a growing prevalence of dyslipidemia
and hypertriglyceridemia in Korea during the last decade
[22].
LIPC encodes hepatic triglyceride lipase, which is
expressed mainly in the liver and is located on 15q21-q23,
where it spans 171 kb and comprises nine exons and eight
introns. Two SNPs [-514C > T (rs1800588) and -250G >
A (rs2070895)] in the promoter region are in almost per-
fect LD (R2 = 0.97) [23,24] and both the promoter SNP
(rs1800588) and the intronic SNP (rs261332) has strong
LD (R2 = 0.92) in HapMap CEU (Caucasians of European
descent from Utah) database [25,26]. The intronic SNPs
rs261332 [26] and rs11858164 [27], and the promoter
SNPs rs1532085 [28] and rs10468017 [29], were associated
with HDL-C levels in genome-wide association studies.
The promoter SNP rs1800588 showed an increase in
HDL-C of 0.04 mmol/l in the CT group and 0.09 mmol/l
in the TT group, compared with the CC carriers [30].
The promoter SNP rs2070895 showed a highly significant
association with a 0.057 mmol/l increase in HDL-C per A
allele (P = 8 × 10-10) [24]. We investigated possible asso-
ciations between LIPC SNPs or diplotypes and HDL-C




A haplotype cluster is defined as a set of haplotypes. A
diplotype is defined as a haplotype cluster pair, the defini-
tion of which is extended from a haplotype pair. The
diplotype is a homozygous diplotype or a heterozygous
diplotype. LD blocks based on Gabriel et al. [31] or the
Four Gamete algorithm [32] or the Solid Spine method
(2), along with the haplotypes generated by EM algorithm,
were used.
The first step produces LD blocks and any haplotypes
for these LD blocks adjusting a threshold frequency,
using Haploview tool.
The second step produces all possible haplotype pairs
from SNP genotypes of samples employing PLINK,
which implements the EM algorithm.
The third step starts with a set of haplotypes, H = {H1,
..., Hn}, which is obtained in the first step. Another set,
HS = {{H1}, ..., {Hn}}, consists of subsets with a single
element of H. Repeat frequency is initialized to 0. The
procedure in this step is as follows.
Procedure: If the length of the HS subset is greater
than the repeat frequency and none of the elements of
the HS subset are equal to any element of H, and the
last element of HS subset is less than each element of
H, each element of H is added to HS subset. In this way,
HS is updated and the repeat frequency increases by
one. The procedure is repeated until the repeat fre-
quency plus one is equal to the total number of H ele-
ments. Table 1 represents an example of the input and
output data (haplotype clusters) in the case of H = {A,
B, C, D}.
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The fourth step produces the patterns of all possible
diplotypes from the results of the third step. Table 2
represents an example of the output data in this step.
The “*” in “{A}/*” indicates a set of all haplotypes except
the “A“ haplotype. Therefore, the set includes not only
the haplotypes with frequencies greater than a threshold,
but also those with frequencies below a threshold.
In the final step, the diplotypes from samples are
transformed into AA, AB, or BB formats according to
the patterns of the diplotypes generated in the fourth
step. For example, the diplotypes, “{A}/*”, consist of
three possible diplotypes, “{A}{A}”, “{A}*”, or “**”, just as
the SNP alleles (A/B) comprise three genotypes (AA,
AB, or BB). That is, input formats for PLINK can be
made from the diplotypes of samples in a population. At
this point, linear or logistic regression analysis can be
carried out by PLINK.
Software
Diplotyper is freely available on the website http://code.
google.com/p/diplotyper/downloads/list.
Subjects
The population data used in the present study was pro-
vided by the Korea Association Resource (KARE) project
from the Korean Genome Epidemiology Study (KoGES),
which is conducted by the Korean National Institute of
Health (KNIH). A cross-sectional analysis of samples
from urban and rural communities in Korea was con-
ducted. The populations [33] were recruited from rural
(Ansung) and urban (Ansan) communities in South
Korea that were part of the KoGES, established in 2001.
A total of 5,018 subjects from the Ansung community
and 5,020 subjects from the Ansan community partici-
pated in the present study. The age of the participants
ranged from 40 to 69 years. A total of 8842 subjects
remained after selection of samples for quality control
purposes [33]. However, an additional 1,306 subjects
who were undergoing treatment for hypertension, dia-
betes, myocardial infarction or hyperlipidemia were
excluded from the study since therapy for these condi-
tions could change HDL-C levels. A detailed list of the
characteristics of the study participants is shown in
Table 3.
Genotyping
All LIPC 38 intronic SNPs available to the research com-
munity through the KARE project from KoGES were ana-
lyzed. The study protocol was approved by the
Institutional Review Board of KNIH. The genotyping of
the samples from the Ansung and Ansan cohorts was per-
formed using the Affymetrix Genome-Wide Human SNP
Array 5.0 (Affymetrix Inc., Santa Clara, CA, USA). The
Bayesian Robust Linear Model with the Mahalanobis
distance genotype-calling algorithm was used with the
Affymetrix SNP array 5.0. The SNPs were filtered if any of
the following criteria were met: i) a call rate lower than
95%, ii) a minor allele frequency (MAF) lower than 0.05,
or iii) a significant deviation from the Hardy-Weinberg
equilibrium (HWE) lower than 1 × 10-6.
Biochemical measures
Biochemical data from the KoGES were obtained
through the KARE project. Blood samples were collected
from the participants after at least eight hours of over-
night fasting. HDL-C concentrations were measured
with the Advia 1650 analyzer (Siemens, Tarrytown, NY,
USA) for the Ansung and Ansan cohorts.
Statistical analyses
To examine possible associations between LIPC SNPs or
diplotypes and HDL-C levels, linear regression analyses
were conducted with adjustments for area, age, gender
and body mass index (BMI). An additive model was
assumed for this study. Log transformation was applied
to HDL-C values to normalize their distribution. Associa-
tions were evaluated as significant at a level of 0.05 after
Bonferroni correction for multiple testing. This conserva-
tive (Bonferroni) adjustment required P values of 2.23 ×
10-4 in HDL-C before correction, since testing of 224
independent hypotheses (38 single-locus and 186 diplo-
type tests) for HDL-C was assumed. To determine the
effects of SNPs and diplotypes, untransformed HDL-C
concentrations were used. Statistical analyses were
Table 1 Haplotype clusters.
Input H = {A, B, C, D}, HS = {{A}, {B}, {C}, {D}}, repeat frequency = 0
Output HS = {{A}, {B}, {C}, {D}, {A, B}, {A, C}, {A, D}, {B, C}, {B, D}, {C, D}, {A, B, C}, {A, B, D}, {A, C, D}, {B, C, D}, {A, B, C, D}}
Example of the input and output data (haplotype clusters) when H = {A, B, C, D}.
Table 2 Patterns of all possible diplotypes.
Output {A}/*, {B}/*, {C}/*, {D}/*, {A, B}/*, {A, C}/*, {A, D}/*, {B, C}/*, {B, D}/*, {C, D}/*, {A, B, C}/*, {A, B, D}/*, {A, C, D}/*, {B, C, D}/*, {A, B, C, D}/*
{A}/{B}, {A}/{C}, {A}/{D}, {B}/{C}, {B}/{D}, {C}/{D}, {A}/{B, C}, {A}/{B, D}, {A}/{C, D}, {B}/{A, C}, {B}/{A, D}, {B}/{C, D}, {C}/{A, B}, {C}/{A, D}, {C}/{B, D}, {D}/{A,
B}, {D}/{A, C}, {D}/{B, C}, {A}/{B, C, D}, {B}/{A, C, D}, {C}/{A, B, D}, {D}/{A, B, C}, {A, B}/{C, D}, {A, C}/{B, D}, {A, D}/{B, C}
Example of the output (diplotypes) produced from the results (input) of the third step.
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performed using PLINK version 1.07 (http://pngu.mgh.
harvard.edu/~purcell/plink) and Python (version 2.7.1;
Python Software Foundation, Wolfeboro Falls, NH).
Results
The total number of tests of association in the additive
model were 224 for HDL-C (data not shown). As shown
in Table 4, out of all LIPC 38 intronic SNPs available to
the research community through the KARE project, only
three SNPs were selected, since these were the only ones
with strong associations with HDL-C that were able to
withstand Bonferroni correction (P < 2.23 × 10-4, see
Methods), on the basis of their diplotypes as well as their
SNP genotypes. The SNP rs261332 had the strongest
association (P value = 3.03 × 10-12) with HDL-C levels.
Figure 1 shows the LD block and the haplotypes for this
block that exhibited frequencies of greater than the 1%
threshold.
Table 5 represents the results of the Diplotyper tool,
which indicate very diverse associations between diplo-
types and HDL-C levels. The top 10 results out of the 40
diplotypes (data not shown) in block 1, in terms of P
value, are shown. The abbreviation b1 means block 1, H12
means the twelfth haplotype cluster, and OH12(*) repre-
sents all other haplotypes (including haplotypes below 1%
frequency), except the H12 haplotype cluster; b1_H12 is a
minor haplotype cluster and b1_OH12(*) a major haplo-
type cluster. The number of one homozygous diplotype (a
b1_H12 pair) was 612, the number of a heterozygous
diplotype (b1_H12 and b1_OH12(*)) was 3,064, and the
number of another homozygous diplotype (a b1_OH12(*)
pair) was 3,858. The strongest association with HDL-C
levels showed a P value of 9.09 × 10-19 and was much
stronger than the P value of the single SNP rs261332.
Figure 2 shows the genealogical tree visualized from
HapStar tool [34]. The haplotypes (AAT or GAC) were
associated with higher HDL-C levels and the haplotypes
(AAC or AGC) were associated with lower HDL-C levels.
The association of AAC / AAT or GAC (different in bold)
with HDL-C levels was statistically significant, but the asso-
ciation of AAC/AGC (different in bold) with HDL-C levels
was not statistically significant in (Table 6, Figure 1, 2).
HL plays a key role in the interconversion between two
HDL subspecies and the indirect pathway of hepatic cho-
lesterol uptake in reverse cholesterol transport with invol-
vement of HDL [13,14]. HDL-C levels are used clinically
to evaluate the risk of developing cardiovascular disease
[21]. The two SNPs (rs1800588 and rs2070895) in the pro-
moter region are in almost perfect linkage disequilibrium
(R2 = 0.97) [24], and both the promoter SNP (rs1800588)
and the intronic SNP (rs261332) show strong LD (R2 =
0.92). The rs2070895 SNP showed a highly significant
association, with a 0.057 mmol/l increase per A allele (P =
8 × 10-10) [24]. In the present study, the rs261332 showed
a significant association (P = 3.03 × 10-12), with a 0.035
mmol/l increase per T allele. The rs11631342 also showed
a significant association (P = 5.66 × 10-6), with a 0.037
mmol/l increase per G allele. The diplotypes b1_H12
(AAT-or-GAC)/b1_OH12(*) (Table 5) showed a strong
association (P = 9.09 × 10-19), with a 0.04 mmol/l increase
per (AAT-or-GAC) haplotype cluster. Transporting cho-
lesterol from peripheral tissues to the liver, HL interferes
Table 4 Associations of single SNPs.
SNP Minor; Major Genotype frequency Effect Standard error P value
rs11631342 G; A 29/923/6583 0.037 0.0083 5.66E-06
rs6494005 G; A 569/2891/4018 -0.023 0.0047 7.43E-07
rs261332 T; C 350/2617/4556 0.035 0.0049 3.03E-12
Associations of single SNPs with HDL-C levels.
Effect sizes (mmol/l) shown are b-coefficients and measured as additive effects, which correspond to the average change in HDL-C levels when one major allele
is replaced with one minor allele.
Table 3 Features of the study subjects.
KARE project
Ansung (n = 3434) Ansan (n = 4102) Total (n = 7536)
Age 54.8 ± 8.8 48.2 ± 7.4 51.2 ± 8.7
Gender
Male (%) 1534 (44.7) 2104 (51.3) 3638 (48.3)
Female (%) 1900 (55.3) 1998 (48.7) 3898 (51.7)
BMI (kg/m2) 24.2 ± 3.2 24.5 ± 2.9 24.4 ± 3.1
HDL-C (mmol/l) 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.1
Features of the study subjects included in the KARE project.
Data are represented as mean ± SD, or as the observed number followed by its corresponding percentage.
BMI, body mass index; HDL, high-density lipoprotein.
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with the interconversions of the mature HDL particles and
acts on the triglyceride-rich HDL, which is able to undergo
hydrolysis to form small HDL particles, which are then
transported to begin anew the process of cholesterol
uptake [13]. Therefore, carriers of rs261332 T-allele and
rs11631342 G-allele may have high HDL-C levels. The
effect of these polymorphisms on HL synthesis may be an
increased susceptibility to cardiovascular disease. The
rs1800588 T-allele, rs2070895 A-allele, rs261332 T-allele,
and rs11631342 G-allele may be of clinical relevance, and
conferring protection against cardiovascular disease, as
there is increasing evidence from population studies that
Figure 1 LD plot of block 1. The LD plot represents the pair-wise D’ and haplotype frequency.
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increasing HDL-C levels reduces the risk of cardiovascular
disease [17-20]. This finding requires replication in an
independent population sample.
Conclusions
Significant haplotype structure has been routinely inves-
tigated to identify haplotypes carrying causative muta-
tions. Many software tools like Haploview [2] and
PLINK [3] provide statistical methods for haplotype
association tests, most of which focus on only a single-
haplotype. Notably, Durrant et al. showed through the
simulation studies and empirical data that their associa-
tion analysis based on haplotype clusters had increased
power over single-locus or single-haplotype tests [10].
That is, they demonstrated the superiority of haplotype
cluster-based association analysis, which extended the
previous method based on the single-haplotype. Never-
theless, the haplotype cluster-based analysis can have
the more limitation of association analysis compared
with diplotype-based analysis as if allele-based analysis
can have less diversity than genotype-based analysis.
Meanwhile, Luo et al. demonstrated that DTR analysis
Table 5 Associations of diplotypes.
Diplotypes Minor; Major Diplotype frequency Effect Standard error P value
b1_H12(AAT-or-GAC)/b1_OH12(*) b1_H12; b1_OH12 612/3064/3858 0.041 0.0044 9.09E-19
b1_H6(AAC-or-AGC)/b1_OH6(*) b1_OH6; b1_H6 617/3064/3853 0.040 0.0044 1.04E-18
b1_H6(AAC-or-AGC)/b1_H12(AAT-or-GAC) b1_H12; b1_H6 612/3059/3853 0.040 0.0044 1.28E-18
b1_H9(AAT)/b1_OH9(*) b1_H9; b1_OH9 346/2616/4572 0.036 0.0049 2.45E-12
b1_H7(AAC-or-AGC-or-GAC)/b1_OH7(*) b1_OH7; b1_H7 350/2618/4566 0.035 0.0049 2.73E-12
b1_H7(AAC-or-AGC-or-GAC)/b1_H9(AAT) b1_H9; b1_H7 346/2612/4566 0.036 0.0049 2.86E-12
b1_H6(AAC-or-AGC)/b1_H9(AAT) b1_H9; b1_H6 346/2375/3853 0.037 0.0052 4.58E-12
b1_H1(AAC)/b1_H12(AAT-or-GAC) b1_H12; b1_H1 612/1933/1498 0.039 0.0057 3.72E-11
b1_H12(AAT-or-GAC)/b1_H13(AGC) b1_H13; b1_H12 564/1126/612 -0.050 0.0075 5.64E-11
b1_H13(AGC)/b1_OH13(*) b1_H13; b1_OH13 564/2922/4048 -0.023 0.0047 6.72E-07
Associations of diplotypes with HDL-C levels (the top 10 results in terms of P value).
Effect sizes (mmol/l) shown are b-coefficients and measured as additive effects, which correspond to the average change in HDL-C levels when one major
haplotype cluster is replaced with one minor haplotype cluster.
Figure 2 Genealogical tree. The thick and thin ellipses have higher and lower HDL-C levels, respectively.
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based on diplotypes outperformed other, more common
association methods [11]; however, they did not apply
haplotype clusters to the DTR analysis.
We developed a novel method that can yield a synergis-
tic effect by combining the positive aspects of analyses
based on haplotype clusters and diplotypes. The Diploty-
per software employs Haploview tool, utilizing LD block
and haplotypes with a frequency threshold. The software
also uses PLINK tool to generate all possible haplotype
pairs in given genotypes of samples and perform associa-
tion analysis using linear or logistic regression. In addition
to employing these existing software tools, we designed a
new procedure to cluster haplotypes of interest from a
large set of haplotypes and implemented a function to
generate the patterns of all possible diplotypes from these
haplotype clusters. Finally, a function to transform diplo-
types into PLINK formats was implemented. All of these
processes were fully automated. We tested our method by
conducting an association analysis between LIPC SNPs or
diplotypes and HDL-C levels. The result showed that our
approach can identify more precise and distinct signals
compared with single-locus tests.
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